RECURSION PHARMACEUTICALS, INC. Earnings Per Share (Basic)
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Earnings Per Share (Basic) of -$0.25 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.25.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.22.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.36.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.41.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$1.44.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$1.69.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.58.
- RECURSION PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$1.36.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.25 10-Q · filed 2026-08-05 | -$0.47 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | -$0.22 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$1.44 10-K · filed 2026-02-25 | |||
| 2025-09-30 | -$0.36 10-Q · filed 2025-11-05 | -$1.27 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | -$0.41 10-Q · filed 2026-08-05 | -$0.91 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | -$0.50 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | -$1.69 10-K · filed 2026-02-25 | |||
| 2024-09-30 | -$0.34 10-Q · filed 2025-11-05 | -$1.12 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | -$0.40 10-Q · filed 2025-08-05 | -$0.79 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$0.39 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | -$1.58 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$0.43 10-Q · filed 2024-11-06 | -$1.16 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$0.38 10-Q · filed 2024-08-08 | -$0.71 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.34 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.36 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$0.35 10-Q · filed 2023-11-09 | -$1.06 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.38 10-Q · filed 2023-08-08 | -$0.71 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.33 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | -$1.49 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$0.28 10-Q · filed 2022-11-08 | -$1.10 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$0.31 10-Q · filed 2021-08-13 | -$0.91 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | -$1.33 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$3.99 10-K · filed 2023-02-27 | |||
| 2020-09-30 | -$1.09 10-Q · filed 2021-11-10 | -$2.82 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$0.88 10-Q · filed 2021-08-13 | -$1.73 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$0.85 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | -$2.87 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |